Challenges and Opportunities in Metastatic Breast Cancer Treatments

Tamoxifen is a cornerstone of HR+ treatment, approved for both pre- and post-menopausal patients to reduce recurrence risk.

Hormone therapies are used for cancers that are hormone receptor-positive (HR+), meaning they use estrogen or progesterone to grow. These drugs either lower hormone levels or block receptors on cancer cells.

Targeted drugs recognize specific markers, typically proteins, that help cancer cells grow and spread.